Drug Profile
Research programme: protein kinase C theta inhibitors - PharmaGap
Latest Information Update: 28 Feb 2014
Price :
$50
*
At a glance
- Originator PharmaGap
- Class Peptides
- Mechanism of Action Protein kinase C theta inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Inflammation; Neurological disorders; Sarcoma
Most Recent Events
- 04 Feb 2013 Discontinued - Preclinical for Inflammation in USA (unspecified route)
- 04 Feb 2013 Discontinued - Preclinical for Neurological disorders in USA (unspecified route)
- 04 Feb 2013 Discontinued - Preclinical for Sarcoma in USA (unspecified route)